Hyaluronate supports hESC‐cardiomyocyte cell therapy for cardiac regeneration after acute myocardial infarction

INTRODUCTION: Enormous progress has been made in cardiac regeneration using human embryonic stem cell‐derived cardiomyocyte (hESC‐CM) grafts in pre‐clinical trials. However, the rate of cell survival has remained very low due to anoikis after transplantation into the heart as single cells. Numerous...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Yuanqing, Wang, Lei, Chen, Gang, Liu, Wenjing, Li, Zhongwen, Wang, Yukai, Wang, Liu, Li, Wei, Wu, Jun, Hao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Manuscripts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705924/
https://www.ncbi.nlm.nih.gov/pubmed/33107673
http://dx.doi.org/10.1111/cpr.12942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705924/
https://www.ncbi.nlm.nih.gov/pubmed/33107673
http://dx.doi.org/10.1111/cpr.12942

Ejemplares similares